Making devices for such chronic conditions as heart failure and Parkinson's disease, Medtronic has an obvious interest in finding better ways of managing long-term disease, and making money in the process.
Once a variant looks like it might be a cause of disease, it is double-checked using Sanger sequencing, the older, more expensive process that was used to create the original draft of the human genome a decade ago.